Maxxeus allograft human product
Closed Solicitation Posted
- Solicitation number
- W81K0025QA147
- Agency
- Medical Command Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- PSC
- 6555 Human Tissue And Cadavers
- Place of performance
- Texas 78154, United States
- Points of contact
-
- James M Davis james.m.davis1.civ@health.mil (210) 221-4267
- Christina Sylvester christina.b.sylvester.civ@health.mil (210) 221-3078
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command is seeking FDA-approved, American Association of Tissue Banks (AATB) and Joint Commission (TJC) compliant allograft human skin tissue and costal cartilage products. The procurement specifically targets Maxxeus Allograft Human Products, including both human skin tissue and costal cartilage variants, with four contract line item numbers identified in the solicitation documents. The original solicitation has been amended to extend the response deadline from September 16, 2025, to September 17, 2025, providing contractors with one additional day to submit their proposals. The procurement falls under NAICS code 339112 (Surgical and Medical Instrument Manufacturing) and PSC code 6555 (Human Tissue and Cadavers), indicating the specialized nature of these medical products. Interested vendors must request the full solicitation via email to obtain complete details and specifications.
This opportunity is designated as a Women-Owned Small Business (WOSB) set-aside with a size standard of 500 employees, limiting competition to qualifying small businesses owned by women. The place of performance is located in Schertz, Texas 78154, near the Fort Sam Houston area where the Army Medical Command is headquartered. The solicitation documents indicate procurement of multiple units across four separate line items, though specific quantities and dollar values are not disclosed in the publicly available notice summary. The procurement appears to be for specialized medical-grade human tissue products that require strict regulatory compliance and certification standards. The tight timeline from posting on September 11, 2025, to the amended deadline of September 17, 2025, suggests this may be an urgent medical supply requirement.
Notice text
2 versions
Update #2 · Latest ·
FDA approved, AATB and TJC compliant Maxxeus Allograft Human Product
Maxxues Allograft Costal Cartilage (2) <= 0.8 cm 4936-25
QTY 12 each
Maxxues Allograft Costal Cartilage (2) <= 0.8 cm 4935-25
QTY 12 each
Maxxues Allograft Costal Cartilage (2) <= 0.8 cm 4929-25
QTY 12 each
Maxxues Allograft Costal Cartilage (2) <= 0.8 cm 4938-25
QTY 12 each
Salient Characteristics:
- Must be Food and Drug Administration (FDA), American Association of Tissue Banks (AATB), and regulated by The Joint Commission (TJC) compliant.
- Must be able to meet standards set forth by the FDA, AATB and TJC and conform to the rules and regulations set forth by the Army Medical Command.
- Must be able to provide a myriad of different tissues, allografts, and supplies associated with surgery.
- May provide safe biologic, metal, and synthetic implants.
- Must provide clinical solutions to wound management, reconstructive surgery, abdominal, and incisional management, but not limited to the items previous cited in the memorandum.
- Must have expediated delivery. Must be able to deliver within 24 hours of receiving an order.
The Government will award a Firm-Fixed-Price (FFP) contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation is the best value to the Government and provides fair and reasonable price. The quote shall conform to the solicitation and be advantageous to the Government. Award will be made using the Lowest Price Technically Acceptable (LPTA) process.
Update #1 ·
FOR A COPY OF THE FULL SOLICITATION, PLEASE SEND AN EMAIL REQUEST
FDA approved, AATB and TJC compliant Allograft Human Skin Tissue Costal Cartilage
Allograft Human Skin Tissue Costal Cartilage (2) <= 0.8 cm 4936-25
QTY 12 each
Allograft Human Skin Tissue Costal Cartilage (2) <= 0.8 cm 4935-25
QTY 12 each
Allograft Human Skin Tissue Costal Cartilage (2) <= 0.8 cm 4929-25
QTY 12 each
Allograft Human Skin Tissue Costal Cartilage (2) <= 0.8 cm 4938-25
QTY 12 each
Salient Characteristics:
- Must be Food and Drug Administration (FDA), American Association of Tissue Banks (AATB), and regulated by The Joint Commission (TJC) compliant.
- Must be able to meet standards set forth by the FDA, AATB and TJC and conform to the rules and regulations set forth by the Army Medical Command.
- Must be able to provide a myriad of different tissues, allografts, and supplies associated with surgery.
- May provide safe biologic, metal, and synthetic implants.
- Must provide clinical solutions to wound management, reconstructive surgery, abdominal, and incisional management, but not limited to the items previous cited in the memorandum.
- Must have expediated delivery. Must be able to deliver within 24 hours of receiving an order.
The Government will award a Firm-Fixed-Price (FFP) contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation is the best value to the Government and provides fair and reasonable price. The quote shall conform to the solicitation and be advantageous to the Government. Award will be made using the Lowest Price Technically Acceptable (LPTA) process.
Attachments
| File | Type | Posted |
|---|---|---|
| Solicitation - W81K0025QA147.pdf | ||
| Solicitation Amendment W81K0025QA1470001 SF 30.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Maxxeus allograft human product | Solicitation | |
| Allograft Human Tissue Products | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity